Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer

27 Jun 2022

Abstract excerpt

Colorectal cancer is a highly malignant cancer with poor prognosis and mortality rates. As the first biological agent approved for metastatic colorectal cancer (mCRC), bevacizumab was confirmed to exhibit good performance when combined with chemotherapy and immunotherapy. However, the efficacy of both bevacizumab and immunotherapy is highly heterogeneous across CRC patients with different stages. Thus, exploring...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Treatments and Studies
Share to Ferroptosis and cancer prognosis
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35833141
DOI: 10.3389/fimmu.2022.910582

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal CancerPMID 35833141Read ↗

An 8-Gene Bevacizumab Resistance Signature Predicts Prognosis and Reveals Immunosuppressive Microenvironment in Colorectal CancerSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals that FBXO2 as a potential therapeutic target associated with immune infiltrationSemantic proximity Read ↗

A comprehensive multi-omics study reveals potential prognostic and diagnostic biomarkers for colorectal cancerSemantic proximity Read ↗

A novel prognostic signature of immune‐related genes for patients with colorectal cancerSemantic proximity Read ↗

Identification and Validation of Prognosis-Associated DNA Repair Gene Signatures in Colorectal CancerSemantic proximity Read ↗

Multi-omics-based analysis of the effect of longevity genes on the immune relevance of colorectal cancerSemantic proximity Read ↗

Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNASemantic proximity Read ↗

Development of a novel hypoxia-immune–related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancerSemantic proximity Read ↗

Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markersSemantic proximity Read ↗

An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancerSemantic proximity Read ↗

Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colorectal cancerSemantic proximity Read ↗

A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.